The ingredient is a patent-pending combination of L-arabinose and chromium.
Glucose-control dietary supplement and food ingredient Prenulin debuted from Pharmachem Laboratories Inc. (Kearny, NJ). The ingredient, a patent-pending combination of a specific form of L-arabinose combined with chromium, is said to significantly lower glucose levels in the body after intake of excessive sugar and help consumers maintain healthy blood glucose levels.
Two separate human clinical studies showed that when Prenulin was consumed, it significantly lowered both circulating glucose and insulin levels after consumption of a 70-g sucrose challenge, compared with placebo. (The studies are described in a peer-reviewed, May 2011 Nutrition Journal article titled “A combination of L-arabinose and chromium lowers circulating glucose and insulin levels after an acute oral sucrose challenge.”
“Normally, it’s sugar in, sugar up,” says Mitch Skop, Pharmachem’s senior director of new product development. “The beauty of Prenulin is that when sugar is consumed, the resulting blood sugar levels have been shown not to spike as they would without the ingredient.”
The company says that Americans typically consume more than twice the recommended amount of sugar each day: 22 tsp per day, or 3 lb of sugar each week. Compare this to the American Heart Association’s recommended upper limit of no more than only 9 tsp per day.
“No doubt about it; the excessive circulating sugars in the body is responsible for dramatic health issues and attendant healthcare costs. This is, in our opinion, the number-one health problem in America,” Skop concludes.
Pharmachem says Prenulin is available in two versions: with Pharmachem’s patented food-bound pre-chelated chromium that is easier to digest, or with Nutrition 21’s Chromax chromium picolinate.